Lalovic B - Search Results

1

Risk-Based Pharmacokinetic and Drug-Drug Interaction Characterization of Antibody-Drug Conjugates in Oncology Clinical Development: An International Consortium for Innovation and Quality in Pharmaceutical Development Perspective.

Li C, Menon R, Walles M, Singh R, Upreti VV, Brackman D, Lee AJ, Endres CJ, Kumar S, Zhang D, Barletta F, Suri A, Hainzl D, Liao KH, Lalovic B, Beaumont M, Zuo P, Mayer AP, Wei D. Li C, et al. Among authors: lalovic b. Clin Pharmacol Ther. 2022 Oct;112(4):754-769. doi: 10.1002/cpt.2448. Epub 2021 Nov 23. Clin Pharmacol Ther. 2022. PMID: 34657311

2

Population Pharmacokinetics and Exposure-Response Analyses for the Most Frequent Adverse Events Following Treatment With Lemborexant, an Orexin Receptor Antagonist, in Subjects With Insomnia Disorder.

Lalovic B, Majid O, Aluri J, Landry I, Moline M, Hussein Z. Lalovic B, et al. J Clin Pharmacol. 2020 Dec;60(12):1642-1654. doi: 10.1002/jcph.1683. Epub 2020 Jul 14. J Clin Pharmacol. 2020. PMID: 32666570 Free PMC article.

3

Evaluation of the CYP3A and CYP2B6 Drug-Drug Interaction Potential of Lemborexant.

Landry I, Aluri J, Nakai K, Hall N, Miyajima Y, Ueno T, Dayal S, Filippov G, Lalovic B, Moline M, Reyderman L. Landry I, et al. Among authors: lalovic b. Clin Pharmacol Drug Dev. 2021 Jun;10(6):681-690. doi: 10.1002/cpdd.915. Epub 2021 Jan 17. Clin Pharmacol Drug Dev. 2021. PMID: 33455055 Free PMC article. Clinical Trial.

4

Physiologically-based pharmacokinetic modeling to predict drug interactions of lemborexant with CYP3A inhibitors.

Ueno T, Miyajima Y, Landry I, Lalovic B, Schuck E. Ueno T, et al. Among authors: lalovic b. CPT Pharmacometrics Syst Pharmacol. 2021 May;10(5):455-466. doi: 10.1002/psp4.12606. Epub 2021 May 1. CPT Pharmacometrics Syst Pharmacol. 2021. PMID: 33704920 Free PMC article.

5

Model-Based Analysis of the Influence of Alcohol Use and Age on Pharmacokinetics-Pharmacodynamics of Oral Oxycodone in Middle-Age and Older Community-Dwelling Adults.

Lalovic BB, Shireman L, Shen DD, Cherrier MM. Lalovic BB, et al. J Clin Pharmacol. 2022 Sep;62(9):1177-1190. doi: 10.1002/jcph.2058. Epub 2022 May 6. J Clin Pharmacol. 2022. PMID: 35394079

6

Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects: role of circulating active metabolites.

Lalovic B, Kharasch E, Hoffer C, Risler L, Liu-Chen LY, Shen DD. Lalovic B, et al. Clin Pharmacol Ther. 2006 May;79(5):461-79. doi: 10.1016/j.clpt.2006.01.009. Clin Pharmacol Ther. 2006. PMID: 16678548 Clinical Trial.

7

Modeling dropout from adverse event data: impact of dosing regimens across pregabalin trials in the treatment of generalized anxiety disorder.

Lalovic B, Hutmacher M, Frame B, Miller R. Lalovic B, et al. J Clin Pharmacol. 2011 May;51(5):706-18. doi: 10.1177/0091270010370973. Epub 2010 Jul 27. J Clin Pharmacol. 2011. PMID: 20663989

8

Pharmacokinetics, Pharmacodynamics, and Safety of the Dual Orexin Receptor Antagonist Lemborexant: Findings From Single-Dose and Multiple-Ascending-Dose Phase 1 Studies in Healthy Adults.

Landry I, Nakai K, Ferry J, Aluri J, Hall N, Lalovic B, Moline ML. Landry I, et al. Among authors: lalovic b. Clin Pharmacol Drug Dev. 2021 Feb;10(2):153-165. doi: 10.1002/cpdd.817. Epub 2020 May 28. Clin Pharmacol Drug Dev. 2021. PMID: 32468649 Free PMC article. Clinical Trial.

9

Exposure-Response Analyses of Polysomnography and Subjective Sleep Efficacy End Points From the Phase 3 Trials of Lemborexant, a Dual Orexin Receptor Antagonist for the Treatment of Insomnia.

Lalovic B, Savant Landry I, Moline M, Reyderman L, Hussein Z. Lalovic B, et al. J Clin Pharmacol. 2023 Apr;63(4):498-511. doi: 10.1002/jcph.2192. Epub 2023 Jan 17. J Clin Pharmacol. 2023. PMID: 36524428 Clinical Trial.

10

Kinetics of B, CD4 T, and CD8 T cells infused into humans: estimates of intravascular:extravascular ratios and total body counts.

Storek J, Lalovic BB, Rupert K, Dawson MA, Shen DD, Maloney DG. Storek J, et al. Among authors: lalovic bb. Clin Immunol. 2002 Mar;102(3):249-57. doi: 10.1006/clim.2001.5174. Clin Immunol. 2002. PMID: 11890711

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters